| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.071 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.02 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.02 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.075 | 0.03 |